pHLIP
Kingston, US · Founded 2014 · Delaware corporation
pHLIP Inc. develops a peptide-based targeted delivery platform (pHLIP, pH-Low Insertion Peptide) that selectively delivers therapeutic and imaging agents to acidic cells in diseased tissues. The technology targets cancer, inflammation, and other acidic tissue diseases by marking, reprogramming, or killing acidic cells.
Founders & leadership
pHLIP was founded in 2014 by OLEG A. ANDREEV, YANA K. RESHETNYAK, and DONALD ENGELMAN.
OA
OLEG A. ANDREEVCo-founder
YK
YANA K. RESHETNYAKCo-founder
DE
DONALD ENGELMANCo-founder
Reported raises · per SEC filings
Form D private placements$7.9M disclosed across 2 rounds · 2017–2018
▶$4.4MraisedOct 2018 · 5 investors · BiotechnologyRule 506(b)
▶$4.4MraisedOct 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- BRIAN NATHDirector
- JASON LEWISPromoter
- DANIEL GREENBERGDirector
- OLEG A. ANDREEVDirector
- DONALD ENGELMANDirector
- DOUGLAS KARPDirector
- YANA K. RESHETNYAKExecutive Officer, Director
- Offering amount
- $4.4M
- Amount sold
- $4.4M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$3.4MraisedSep 2017 · 5 investors · BiotechnologyRule 506(b)
▶$3.4MraisedSep 2017 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- OLEG A. ANDREEVDirector
- JASON LEWISPromoter
- YANA K. RESHETNYAKExecutive Officer, Director
- DONALD ENGELMANDirector
- Offering amount
- $3.4M
- Amount sold
- $3.4M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with pHLIP for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does pHLIP do?
- pHLIP Inc. develops a peptide-based targeted delivery platform (pHLIP, pH-Low Insertion Peptide) that selectively delivers therapeutic and imaging agents to acidic cells in diseased tissues. The technology targets cancer, inflammation, and other acidic tissue diseases by marking, reprogramming, or killing acidic cells.
- Who founded pHLIP?
- pHLIP was founded by OLEG A. ANDREEV, YANA K. RESHETNYAK, DONALD ENGELMAN in 2014.
- How much funding has pHLIP raised?
- pHLIP has disclosed $7.9M raised across 2 rounds.
- Where is pHLIP headquartered?
- pHLIP is headquartered in Kingston, US.